Myeloproliferative Neoplasm (MPN) Australia Limited
In 2023, we continued to support ongoing research collaborations and projects which demonstrate potential to improve the lives of people with Myeloproliferative Neoplasms (MPNs) including Essential Thrombocytosis (ET), Polycythemia Vera (PV) and Myelofibrosis (MF). Ruby Red Foundation continued to participate in an international network for organisations which aim to improve the lives of people with Myeloprolierative Neoplasms, as well as maintaining an online presence for people with MPNs, including children and their families.
Only Active in Australia
Contact Myeloproliferative Neoplasm (MPN) Australia Limited
You have reached your maximum submissions.